◢ TECHNICA.BIOBIOTECH ECOSYSTEM INTELLIGENCE
Polish Biotech Scene

StethoMe

AI home stethoscope · Respiratory (asthma) monitoring

MarketVC-backed (private)PoznańAI-Driven Drug Discovery
Focus / modality
AI home stethoscope
Lead asset
StethoMe stethoscope
Type
Diagnostics / AI
Indication
Respiratory (asthma) monitoring
Stage
Market
HQ
Poznań
Capital tier
VC-backed (private)
Backing
VC

Overview

CE-certified AI stethoscope for home detection of abnormal respiratory sounds, integrated with telemedicine.

What they do

StethoMe is a Polish (Poznań-area) medtech company that has developed a CE-certified AI-powered wireless stethoscope for home use. The system combines an electronic stethoscope, a mobile app and proprietary AI algorithms that let untrained users record auscultation: the app guides probe placement, and StethoMe AI immediately analyzes lung sounds to detect and classify pathological sounds such as wheezes and crackles linked to conditions like asthma, bronchitis and pneumonia. The platform is designed to integrate with telemedicine, enabling clinicians to review recordings remotely.

Lead program & status

The lead product is the StethoMe stethoscope with its AI analysis engine, focused on respiratory (asthma) monitoring, initially in children. It is a certified Class IIa medical device in the EU (CE) and is sold in markets including Poland, France and the UK. The company has raised venture funding across pre-seed, seed and Series A rounds (reported figures include roughly a $2M seed and $2.5M Series A) plus nearly $3M in NCBR grants. StethoMe has targeted US/FDA clearance, reportedly expected around 2025, and showcased the device at CES 2025. Peer-reviewed work has examined AI-aided home monitoring of asthma exacerbations.

Why it matters

Home auscultation with automated sound analysis can support remote management of chronic respiratory disease, helping families and clinicians catch asthma exacerbations earlier without an in-person visit.

FAQ

What does the StethoMe stethoscope do?
It is an AI home stethoscope that records lung sounds and automatically detects abnormal respiratory sounds like wheezes and crackles, integrated with telemedicine.
Is StethoMe regulatory-approved?
It is a CE-certified Class IIa medical device sold in the EU; the company has targeted US/FDA clearance, reportedly expected around 2025.
What conditions is StethoMe used for?
It focuses on respiratory monitoring, especially asthma, with relevance to conditions such as bronchitis and pneumonia, initially aimed at children.

Technology

StethoMe works in AI-Driven Drug Discovery — Compressing years of trial-and-error chemistry into months of computation.

Read the AI-Driven Drug Discovery brief →

Related companies

Company website / source ↗ Open the interactive map →

◢ Boom-cycle briefing

Get ahead of the next biotech boom.

New companies, stage changes, deal alerts and fresh tech briefs — one sharp email when the map moves.

No spam · ~1–2 emails/month · unsubscribe anytime.
Curated biotech intelligence, compiled for orientation — not investment advice. Company stages, deals and figures move fast; verify against ClinicalTrials.gov, company filings and primary sources before acting.